87 related articles for article (PubMed ID: 8356541)
1. Pharmacokinetics of acipimox and of its N-deoxy metabolite following single and repeated oral administration to healthy volunteers.
Efthymiopoulos C; Strolin Benedetti M; Poggesi I; Ruff F; Basileo G; Musatti L
Therapie; 1993; 48(1):23-6. PubMed ID: 8356541
[TBL] [Abstract][Full Text] [Related]
2. [The pharmacokinetics and bioequivalence of acipimox sustained-release tablets after a single and multiple oral administration in healthy dogs].
Yang XG; Nie SF; Bai HJ; Zhang GJ; Pan WS
Yao Xue Xue Bao; 2005 May; 40(5):457-61. PubMed ID: 16220793
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics of fentiazac and its metabolite, p-hydroxyfentiazac, after twice-daily oral administration to male volunteers.
Dowell PS; Pierce DM; Franklin RA; Norris R; Harries H; Whiteland H
Xenobiotica; 1984 Dec; 14(12):947-53. PubMed ID: 6531942
[TBL] [Abstract][Full Text] [Related]
4. Relative bioavailability of different butamirate citrate preparations after single dose oral administration to 18 healthy volunteers.
Bohner H; Janiak PS; Nitsche V; Eichinger A; Schütz H
Int J Clin Pharmacol Ther; 1997 Mar; 35(3):117-22. PubMed ID: 9089001
[TBL] [Abstract][Full Text] [Related]
5. An open-label, crossover study of the pharmacokinetics of Insoluble Drug Delivery-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers.
Penn R; Williams RX; Guha-Ray DK; Sawyers WG; Braun SL; Rains KT
Clin Ther; 2006 Jan; 28(1):45-54. PubMed ID: 16490579
[TBL] [Abstract][Full Text] [Related]
6. Plasma pharmacokinetics of cinmetacin following oral administration in healthy volunteers.
Danesi R; Ducci M; Acerbi D; Del Tacca M
Arzneimittelforschung; 1988 Jan; 38(1):129-31. PubMed ID: 3259136
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics, safety, and tolerability of R411, a dual alpha4beta1-alpha4beta7 integrin antagonist after oral administration at single and multiple once-daily ascending doses in healthy volunteers.
Hijazi Y; Welker H; Dorr AE; Tang JP; Blain R; Renzetti LM; Abbas R
J Clin Pharmacol; 2004 Dec; 44(12):1368-78. PubMed ID: 15545307
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
Smith WB; Dowell JA; Pratt RD
Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
[TBL] [Abstract][Full Text] [Related]
9. Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus.
von Nicolai H; Brickl R; Eschey H; Greischel A; Heinzel G; König E; Limmer J; Rupprecht E
Arzneimittelforschung; 1997 Mar; 47(3):247-52. PubMed ID: 9105542
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetics and bioequivalence of two peroral beclobrate preparations].
Gikalov I; Ifflaender U
Arzneimittelforschung; 1987 Sep; 37(9):1065-8. PubMed ID: 3435603
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
[TBL] [Abstract][Full Text] [Related]
14. A new fenofibrate formulation: results of six single-dose, clinical studies of bioavailability under fed and fasting conditions.
Guivarc'h PH; Vachon MG; Fordyce D
Clin Ther; 2004 Sep; 26(9):1456-69. PubMed ID: 15531008
[TBL] [Abstract][Full Text] [Related]
15. Single and repeated dose pharmacokinetics of dexketoprofen trometamol in young and elderly subjects.
Valles J; Artigas R; Bertolotti M; Crea A; Muller F; Paredes I; Capriati A
Methods Find Exp Clin Pharmacol; 2006 Jun; 28 Suppl A():13-9. PubMed ID: 16801988
[TBL] [Abstract][Full Text] [Related]
16. Single- and repeated-dose pharmacokinetics of intramuscular thiocolchicoside in healthy volunteers.
Weinling E; Sandouk P; Debray M; Scherrmann JM
Int J Clin Pharmacol Ther; 1999 Oct; 37(10):503-9. PubMed ID: 10543318
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic profile of a new 3-azinomethyl rifamycin (SPA-S-565) in volunteers as compared with conventional rifampicin.
Kelkar MS; Saraf AP; Bakhle DS; Nazare V; Ajay S; Hegde S; Lal HM; Cooverji ND; Bruzzese T
Int J Clin Pharmacol Res; 1998; 18(3):137-43. PubMed ID: 9825270
[TBL] [Abstract][Full Text] [Related]
18. Smoking behaviour modulates pharmacokinetics of orally administered clopidogrel.
Yousef AM; Arafat T; Bulatova NR; Al-Zumyli R
J Clin Pharm Ther; 2008 Aug; 33(4):439-49. PubMed ID: 18613862
[TBL] [Abstract][Full Text] [Related]
19. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects.
Kim SD; Kang W; Lee HW; Park DJ; Ahn JH; Kim MJ; Kim EY; Kim SW; Nam HS; Na HJ; Yoon YR
Clin Ther; 2009 Apr; 31(4):793-803. PubMed ID: 19446152
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of clopidogrel.
Caplain H; Donat F; Gaud C; Necciari J
Semin Thromb Hemost; 1999; 25 Suppl 2():25-8. PubMed ID: 10440419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
